Skip to main content

The Expression of Growth Hormone-Releasing Hormone (GHRH) and its Receptor Splice Variants in Human Breast Cancer Lines; The Evaluation of Signaling Mechanisms in the Stimulation of Cell Proliferation

Breast Cancer Research and Treatment volume 77, pages 15–26 (2003)Cite this article

Abstract

Antagonists of growth hormone-releasing hormone (GHRH) inhibit growth of various human cancers including breast cancer, xenografted into nude mice or cultured in vitro. Splice variants (SVs) of receptors for GHRH have been found in several human cancers and cancer cell lines. The antiproliferative actions of GHRH antagonists could be mediated in part through these SVs of GHRH receptors. In this study we examined the expression of mRNA for GHRH and SVs of its receptors in human breast cancer cell lines MCF-7, MCF-7MIII, MDA-MB-231, MDA-MB-435, MDA-MB-468, and T47D. mRNA for GHRH was present in all lines tested. mRNA for SV1 isoform of GHRH receptors was found in MCF-7MIII, MDA-MB-468, and T47D; and for SV2 isoform in MCF-7MIII and T47D cell lines. In proliferation studies in vitro, the growth of T47D cells was stimulated by GHRH and dose-dependently inhibited by GHRH antagonist JV-1-38. H89 (protein kinase A inhibitor), bisindolylmaleimide I (protein kinase C [PKC] inhibitor) and verapamil (voltage-dependent calcium channel blocker) inhibited the GHRH-stimulated proliferation of T47D cells. The GHRH antagonist JV-1-38 suppressed the T47D cell growth in vitro stimulated by PKC activator (phorbol-12-myristate-13-acetate). The stimulation of T47D cells by GHRH was followed by an increase in cAMP production and GHRH antagonist JV-1-38 competitively inhibited this effect. Our results suggest that SVs of GHRH receptors could mediate the responses to GHRH and GHRH antagonists in breast cancer through Ca2+-, cAMP- and PKC-dependent mechanisms. The presence of SV1 of GHRH receptors in human cancers provides a rationale for antitumor therapy based on the blockade of this receptor by specific GHRH antagonists.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics 2002. CA-Cancer J Clin 52: 23-47, 2002

    Google Scholar 

  2. Apantaku LM: Breast cancer diagnosis and screening. Am Fam Physician 62: 596-602, 2000

    Google Scholar 

  3. Osborne CK, Arteaga CL: Autocrine and paracrine growth regulation of breast cancer: clinical implications. Breast Cancer Res Tr 15: 3-11, 1990

    Google Scholar 

  4. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE: Effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244, 2000

    Google Scholar 

  5. Schally AV, Comaru-Schally AM: In: Holland JF, Frei II E, Bast Jr RC, Kufe DW, Pollock RE, Weichselbaum RR (eds) Cancer Medicine. 5th edn, Dekker, New York, 2000, pp 715-729

    Google Scholar 

  6. Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, Varga JL, Halmos G: Hypothalamic hormones and cancer. Front Neuroendocrin 22: 248-291, 2001

    Google Scholar 

  7. Schally AV, Varga JL: Antagonistic analogs of growth hormone-releasing hormone (GH-RH): new potential antitumor agents. Trends Endocrin Met 10: 383-391, 1999

    Google Scholar 

  8. Kahan Z, Varga JL, Schally AV, Rekasi Z, Armatis P, Chatzistamou I, Czompoly T, Halmos G: Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice. Breast Cancer Res Tr 60: 71-79, 2000

    Google Scholar 

  9. Chatzistamou I, Schally AV, Varga JL, Groot K, Busto R, Armatis P, Halmos G: Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone. Anti-Cancer Drug 12: 761-768, 2001

    Google Scholar 

  10. Szepeshazi K, Schally AV, Armatis P, Groot K, Hebert F, Feil A, Varga JL, Halmos G: Antagonists of GHRH decrease production of GH and IGF-1 in MXT mouse mammary cancers and inhibit tumor growth. Endocrinology 142: 4371-4378, 2001

    Google Scholar 

  11. Pollack MN: Endocrine effects of IGF-I on normal and transformed breast epithelial cells; potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Tr 47: 209-217, 1998

    Google Scholar 

  12. Mol JA, Henzen-Logmans SC, Hageman Ph, Misdorp W, Blankenstein MA, Rijnberk A: Expression of the gene encoding growth hormone in the human mammary gland. J Clin Endocr Metab 80: 3094-3096, 1995

    Google Scholar 

  13. Csernus VJ, Schally AV, Kiaris H, Armatis P: Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro. P Natl Acad Sci USA 96: 3098-3103, 1999

    Google Scholar 

  14. Kiaris H, Schally AV, Varga JL, Groot K, Armatis P: Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma. P Natl Acad Sci USA 96: 14894-14898, 1999

    Google Scholar 

  15. Rekasi Z, Varga JL, Schally AV, Halmos G, Armatis P, Groot K, Czompoly T: Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers. Endocrinology 141: 2120-2128, 2000

    Google Scholar 

  16. Chatzistamou I, Schally AV, Varga JL, Groot K, Armatis P, Busto R, Halmos G: Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice. J Clin Endocr Metab 86: 2144-2152, 2001

    Google Scholar 

  17. Busto R, Schally AV, Braczkowski R, Plonowski A, Krupa M, Groot K, Armatis P, Varga JL: Expression of mRNA for growth hormone-releasing hormone (GHRH), and splice variants of GHRH receptors in human malignant bone tumors. Regul Peptides 2002 (in press)

  18. Chopin LK, Herington AC: A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines. Prostate 49: 116-121, 2001

    Google Scholar 

  19. Plonowski A, Schally AV, Busto R, Krupa M, Varga JL, Halmos G: Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers. Peptides 23: 1127-1133, 2002

    Google Scholar 

  20. Kahan Z, Arencibia J, Csernus V, Groot K, Kineman R, Robinson WR, Schally AV: Expression of growth hormonereleasing hormone (GH-RH) messenger ribonucleic acid and the presence of biologically active GH-RH in human breast, endometrial, and ovarian cancers. J Clin Endocr Metab 84: 582-589, 1999

    Google Scholar 

  21. Khorram O, Garthwaiter M, Grosen E, Golos T: Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Fertil Steril 75: 174-179, 2001

    Google Scholar 

  22. Kineman RD: Antitumorigenic actions of growth hormonereleasing hormone antagonists. P Natl Acad Sci USA 97: 532-534, 2000

    Google Scholar 

  23. Benlot C, Levy L, Fontanaud P, Roche A, Rouannet P, Joubert D: Somatostatin and growth hormone-releasing hormone in normal and tumoral human breast tissue: endogenous content, in vitro pulsatile release, and regulation. J Clin Endocr Metab 82: 690-696, 1997

    Google Scholar 

  24. Gaylinn BD, Harrison JK, Zysk JR, Lyons CE, Lynch KR, Thorner MO: Molecular cloning and expression of human anterior pituitary receptor for growth hormone-releasing hormone. Mol Endocrinol 7: 77-84, 1993

    Google Scholar 

  25. Gaylinn BD: Molecular and cell biology of the growth hormone-releasing hormone receptor. Growth Horm IGF Res 9: 37-44, 1999

    Google Scholar 

  26. Rekasi Z, Czompoly T, Schally AV, Halmos G: Isolation and sequencing of cDNAs for splice variants of growth hormonereleasing hormone receptors for human cancers. P Natl Acad Sci USA 97: 10561-10566, 2000

    Google Scholar 

  27. Halmos G, Schally AV, Varga JL, Plonowski A, Rekasi Z, Czompoly T: Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone. P Natl Acad Sci USA 97: 10555-10560, 2000

    Google Scholar 

  28. Kiaris H, Schally AV, Busto R, Halmos G, Artavanis-Tsakonas S, Varga JL: Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. P Natl Acad Sci USA 99: 196-200, 2002

    Google Scholar 

  29. Müller EE, Locatelli V, Cocchi D: Neuroendocrine control of growth hormone secretion. Physiol Rev 79: 511-607, 1999

    Google Scholar 

  30. Ramirez JL, Cataho JP, Torronteras R, Martinez-Fuentes AJ, Frawley LS, Garcia-Navarro S, Gracia-Navarro F: Growth hormone (GH)-releasing factor differentially activates cyclic adenosine 3′,5′-monophosphate-and inositol phosphatedependent pathways to stimulate GH release in two porcine somatotrope subpopulations. Endocrinology 140: 1752-1759, 1999

    Google Scholar 

  31. Rekasi Z, Varga JL, Schally AV, Plonowski A, Halmos G, Csernus B, Armatis P, Groot K: Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways. Peptides 22: 879-886, 2001

    Google Scholar 

  32. Varga JL, Schally AV, Csernus V, Zarandi M, Halmos G, Groot K, Rekasi Z: Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. P Natl Acad Sci USA 96: 692-697, 1999

    Google Scholar 

  33. Reile H, Birnbock H, Bernhardt G, Spruss T, Schonenberger H: Computerized determination of growth kinetic curves doubling times from cells in microculture. Anal Biochem 187: 262-267, 1990

    Google Scholar 

  34. Busto R, Carrero I, Zapata P, Colas B, Prieto JC: Multiple regulation of adenylyl cyclase activity by G-protein coupled receptors in human foetal lung fibroblasts. Regul Peptides 95: 53-58, 2000

    Google Scholar 

  35. Csernus V, Schally AV, Groot K: Antagonistic analogs of growth hormone-releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro. Peptides 20: 843-850, 1999

    Google Scholar 

  36. Garcia-Fernandez MO, Solano RM, Sanchez-Chapado M, Ruiz-Villaespesa A, Prieto JC, Carmena MJ: Low expression of Gα protein subunits in human prostate cancer. J Urology 166: 2512-2517, 2001

    Google Scholar 

  37. Dhanasekaran N, Tsim ST, Dermott JM, Onesime D: Regulation of cell proliferation by G-proteins. Oncogene 17: 1383-1394, 1998

    Google Scholar 

  38. Morris AJ, Malbon CC: Physiological regulation of G proteinlinked signaling. Physiol Rev 79: 1373-1430, 1999

    Google Scholar 

  39. Takei T, Takano K, Yasufuku-Takano J, Fujita T, Yamashita N: Enhancement of Ca2+ currents by GHRH and its relation to PKA and [Ca2+]I in human GH-secreting adenoma cells. Am J Physiol 271: E801-E807, 1996

    Google Scholar 

  40. Kato M, Sakuma Y: Regulation by growth hormone-releasing hormone and somatostatin of Na+ current in the primary cultured rat somatrotroph. Endocrinology 138: 5096-5100, 1997

    Google Scholar 

  41. Xu R, Roh S-G, Loneragan K, Pullar M, Chen C: Human GHRH reduces voltage-gated K+ currents via a non-cAMPdependent but PKC-mediated pathway in human GH adenoma cells. J Physiol-London 520: 697-707, 1999

    Google Scholar 

  42. Clapham DE, Neer EJ: G protein βγ subunits. Annu Rev Pharmacol 37: 167-203, 1997

    Google Scholar 

  43. Sternweis PC, Smrcka AV: G proteins in signal transduction: the regulation of phospholipase C. Ciba F Symp 176: 96-106, 1993

    Google Scholar 

  44. Camps M, Carozzi A, Schnabel P, Scheer A, Parker PJ, Gierschik P: Isozyme-selective stimulation of phospholipase C-β2 by G protein βγ-subunits. Nature 360: 684-686, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, New Orleans, LA, USA

    M. Olga Garcia-Fernandez, Andrew V. Schally, Jozsef L. Varga, Kate Groot & Rebeca Busto

  2. Section of Experimental Medicine, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA

    M. Olga Garcia-Fernandez, Andrew V. Schally, Jozsef L. Varga & Rebeca Busto

Authors
  1. M. Olga Garcia-Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew V. Schally
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jozsef L. Varga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kate Groot
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rebeca Busto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Garcia-Fernandez, M.O., Schally, A.V., Varga, J.L. et al. The Expression of Growth Hormone-Releasing Hormone (GHRH) and its Receptor Splice Variants in Human Breast Cancer Lines; The Evaluation of Signaling Mechanisms in the Stimulation of Cell Proliferation. Breast Cancer Res Treat 77, 15–26 (2003). https://doi.org/10.1023/A:1021196504944

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021196504944

  • anticancer drugs
  • autocrine growth factors
  • breast cancer
  • GHRH
  • GHRH antagonists
  • GHRH receptors